The wireless type segment by type is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Surgical Smart Glasses Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, End User and Country.” The North America surgical smart glasses market is expected to reach US$ 1,40,447.96 thousand by 2028 from US$ 65,626.48 thousand in 2021; it is estimated to grow at a CAGR of 10.2% from 2021 to 2028. The report highlights trends prevailing in the North America surgical smart glasses market and the factors driving market along with those that act as hindrances. 

Smart glasses and wearable computing devices are being used by healthcare professionals across the world during surgeries. The smart glasses help them produce superior outcomes by enabling the functionalities of standard computers, including voice commands, eye movements, gestures, and simple tactile commands. Moreover, these glasses aid in the real-time visualization of bones and tissues on the paired screen during surgeries. They also help increase surgical precision and reduce overall surgical procedural duration by 30%. Many surgical procedures are associated with the possibility of certain adversities, which might as well lead to mortality. Therefore, in crucial cases, it becomes essential to utilize advanced equipment to avoid possible ill-effects. According to a study published by the World Health Organization (WHO) in 2019, unsafe medical care causes ~2.6 million deaths every year in the low- and middle-income countries. Such a vast extent of lethality is anticipated to boost the adoption of surgical smart glasses and other advanced tools and devices during the forecast period. The rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular diseases (CVDs), stroke, and kidney diseases, is leading to surge in the number of surgical procedures being performed, which would eventually boost the surgical smart glasses market growth.

Companies in North America are taking several initiatives for combating the COVID-19 pandemic. In January 2021, BioSig Technologies, Inc. announced a partnership with Vuzix Corporation, a leading supplier of smart glasses and augmented reality (AR) technology and products. BioSig Technologies, a medical technology company, is commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals. It would deploy Vuzix's M400 Smart Glasses for the remote servicing of its PURE EP System, as a part of the nationwide rollout plan of BioSig's novel real-time signal processing platform to the large and growing electrophysiology market in the US. The remote servicing support offers an ideal solution for the travel restrictions imposed amid the pandemic. Thus, the elevating awareness about remote clinical support option available for surgeons is contributing to the surgical smart glasses market growth.

Based on type, the North America surgical smart glasses market is segmented into wire type and wireless type. Based on end user, the North America surgical smart glasses market is segmented into hospital, clinics, and others. Geographically, the North America micropump market can be sub-segmented into U.S. Mexico and Canada.

Taiwan Main Orthopaedic Biotechnology, IRISTICK, Vuzix Corporation, AMA XpertEye, ImmersiveTouch, Inc., and Microsoft HoloLens (Microsoft Corporation) are among the leading companies operating in the North America surgical smart glasses market.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com